Drug-Drug Interaction (DDI) Regulatory Guide
- 16 February 2021
- Resource Type: ADME/DMPK, Guides, IND Enabling Studies/Preclinical Development
Our popular, easy-to-follow guide: ‘DDI Regulatory Guidance’ is now on its 3rd edition.
Read about:
- an easy to follow summary and comparison of the latest DDI guidance from the FDA and the EMA
- a focus on reaction phenotyping, cytochrome P450 inhibition, cytochrome P450 induction, drug transporter substrate studies and drug transporter inhibition
- an overview of the regulatory methods and interpretation of data
Sounds interesting?
Enter your details below to continue reading…
